Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MIGALASTAT vs MILNACIPRAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MIGALASTAT vs MILNACIPRAN: Safety Overview

Metric MIGALASTAT MILNACIPRAN
Total FAERS Reports 481 1,392
Deaths Reported 60 120
Death Rate 12.5% 8.6%
Hospitalizations 160 274
Average Patient Age 54.6 yrs 54.8 yrs
% Female Patients 56.4% 82.6%
FDA Approval Date Aug 10, 2018 Apr 22, 2016
Manufacturer Amicus Therapeutics US, LLC Cardinal Health 107, LLC
Route ORAL ORAL
Marketing Status Prescription Prescription